Status:
COMPLETED
Effect on the Adherence to Glaucoma Eye Drops by Improving Patient Understanding and Using a Tele-reminder System
Lead Sponsor:
National University Health System, Singapore
Conditions:
Glaucoma
Eligibility:
All Genders
30-90 years
Phase:
PHASE2
Brief Summary
To determine the improvement in patient adherence to topical ocular hypotensive therapy by introducing a personalised illustrated medication reference chart and tele-reminder.
Detailed Description
This is a randomized controlled clinical trial study with patients recruited from the National University Hospital, Singapore who met eligibility criteria and agreed to participate in the study during...
Eligibility Criteria
Inclusion
- Patients who have been treated for glaucoma for at least 3 months
- Using a total of three or more eye drops, at least two of which are ocular hypotensive
- A minimum visual acuity of 6/60 or better
- Aged 30 to 90 years old
Exclusion
- Patients who just started on glaucoma treatment
- Patients who are on less than 3 eyedrops
- Patients with vision worse than 6/60
Key Trial Info
Start Date :
October 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 19 2019
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT04317573
Start Date
October 19 2018
End Date
October 19 2019
Last Update
March 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yien Lai
Singapore, Singapore, 119074